Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanamura

Showing results (491-500 of 531) with videos related to

Pageof 54
Sort By:
Marine Drugs|June 25, 2026
Ascophyllan Supplementation Is Safe and Associated with Exploratory Modulation of Innate Immune Phenotypes, Biochemical Parameters, and the Gut Microbiome in a Randomized Pilot TrialShohei Mizuno, Jorge Luis Espinoza, Lam Quang Vu, et al.
Leukemia Research|June 29, 2013
Growth of xenotransplanted leukemia cells is influenced by diet nutrients and is attenuated with 2-deoxyglucoseNorikazu Tsunekawa-Imai, Hiroshi Miwa, Masato Shikami, et al.
Breast Cancer Research and Treatment|December 9, 2022
Clinicopathological features, genetic alterations, and BRCA1 promoter methylation in Japanese male patients with breast cancerAkihiko Shimomura, Masayuki Yoshida, Takashi Kubo, et al.
Oncotarget|May 10, 2017
Toll-like receptor genetic variations in bone marrow transplantationKaori Uchino, Shohei Mizuno, Aiko Sato-Otsubo, et al.
Genes and Immunity|February 25, 2021
Donor UNC-93 Homolog B1 genetic polymorphism predicts survival outcomes after unrelated bone marrow transplantationKaori Uchino, Lam Vu Quang, Shohei Mizuno, et al.
Anticancer Research|May 7, 2017
Efficacy and Safety Analysis of Oxaliplatin-based Chemotherapy for Advanced Gastric CancerKyoko Inadomi, Hitoshi Kusaba, Yuzo Matsushita, et al.
Acta Haematologica|September 17, 2020
Pretreatment Immature Platelet Fraction as a Surrogate of Reticulated Platelets Predicts the Response to Corticosteroids in Adults with Immune ThrombocytopeniaAkiyoshi Takami, Shohei Mizuno, Ayano Nakamura, et al.
Blood|June 2, 2011
Pharmacogenomics of bortezomib test-dosing identifies hyperexpression of proteasome genes, especially PSMD4, as novel high-risk feature in myeloma treated with Total Therapy 3John D Shaughnessy, Pingping Qu, Saad Usmani, et al.
Cancer Science|February 26, 2018
Bortezomib plus dexamethasone vs thalidomide plus dexamethasone for relapsed or refractory multiple myelomaShinsuke Iida, Masashi Wakabayashi, Kunihiro Tsukasaki, et al.
Clinical Hematology International|August 11, 2025
Consensus Guidelines and Recommendations for the anti-CD38-based Therapy in Clinical Practice for Relapsed/Refractory Multiple Myeloma: From the Pan-Pacific Multiple Myeloma Working GroupWenming Chen, Zhen Cai, Chor Sang Chim, et al.
Pageof 54

Showing results (491-500 of 531) with videos related to

Sort By:
Pageof 54
Marine Drugs|June 25, 2026
Ascophyllan Supplementation Is Safe and Associated with Exploratory Modulation of Innate Immune Phenotypes, Biochemical Parameters, and the Gut Microbiome in a Randomized Pilot TrialShohei Mizuno, Jorge Luis Espinoza, Lam Quang Vu, et al.
Leukemia Research|June 29, 2013
Growth of xenotransplanted leukemia cells is influenced by diet nutrients and is attenuated with 2-deoxyglucoseNorikazu Tsunekawa-Imai, Hiroshi Miwa, Masato Shikami, et al.
Breast Cancer Research and Treatment|December 9, 2022
Clinicopathological features, genetic alterations, and BRCA1 promoter methylation in Japanese male patients with breast cancerAkihiko Shimomura, Masayuki Yoshida, Takashi Kubo, et al.
Oncotarget|May 10, 2017
Toll-like receptor genetic variations in bone marrow transplantationKaori Uchino, Shohei Mizuno, Aiko Sato-Otsubo, et al.
Genes and Immunity|February 25, 2021
Donor UNC-93 Homolog B1 genetic polymorphism predicts survival outcomes after unrelated bone marrow transplantationKaori Uchino, Lam Vu Quang, Shohei Mizuno, et al.
Anticancer Research|May 7, 2017
Efficacy and Safety Analysis of Oxaliplatin-based Chemotherapy for Advanced Gastric CancerKyoko Inadomi, Hitoshi Kusaba, Yuzo Matsushita, et al.
Acta Haematologica|September 17, 2020
Pretreatment Immature Platelet Fraction as a Surrogate of Reticulated Platelets Predicts the Response to Corticosteroids in Adults with Immune ThrombocytopeniaAkiyoshi Takami, Shohei Mizuno, Ayano Nakamura, et al.
Blood|June 2, 2011
Pharmacogenomics of bortezomib test-dosing identifies hyperexpression of proteasome genes, especially PSMD4, as novel high-risk feature in myeloma treated with Total Therapy 3John D Shaughnessy, Pingping Qu, Saad Usmani, et al.
Cancer Science|February 26, 2018
Bortezomib plus dexamethasone vs thalidomide plus dexamethasone for relapsed or refractory multiple myelomaShinsuke Iida, Masashi Wakabayashi, Kunihiro Tsukasaki, et al.
Clinical Hematology International|August 11, 2025
Consensus Guidelines and Recommendations for the anti-CD38-based Therapy in Clinical Practice for Relapsed/Refractory Multiple Myeloma: From the Pan-Pacific Multiple Myeloma Working GroupWenming Chen, Zhen Cai, Chor Sang Chim, et al.
Pageof 54